Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polymeric nanoparticles for gene delivery.

Jaspreet K Vasir1, Vinod Labhasetwar

  • 1Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198-6025, USA.

Expert Opinion on Drug Delivery
|April 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolving role of biomarkers in spinal cord injury: From research to clinical translation.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Efficacy and Safety of Dual Paclitaxel and Sirolimus Nanoparticle-Coated Balloon.

JACC. Basic to translational science·2024
Same author

Nanoparticle-mediated delivery of tetrahydrobiopterin restores endothelial function in diabetic rats.

Nitric oxide : biology and chemistry·2024
Same author

Catalytic antioxidant nanoparticles mitigate secondary injury progression and promote functional recovery in spinal cord injury model.

Journal of controlled release : official journal of the Controlled Release Society·2023
Same author

Nanoparticle-mediated synergistic drug combination for treating bone metastasis.

Journal of controlled release : official journal of the Controlled Release Society·2023
Same author

Nanotechnology in Stroke: New Trails with Smaller Scales.

Biomedicines·2023
Same journal

Dry powder inhaler selection in COPD: integrating device design, formulation performance, and patient inspiratory capability.

Expert opinion on drug delivery·2026
Same journal

Letter to the Editor: 'saving money but costing lives: the lack of integrated dose counters on pressurised metered dose inhalers'.

Expert opinion on drug delivery·2026
Same journal

Response to letter to the editor: 'Saving money but costing lives: the lack of integrated dose counters on pressurised metered dose inhalers'.

Expert opinion on drug delivery·2026
Same journal

Mechanism-guided metal complex therapeutics for biofilm-driven wound infections and transdermal delivery.

Expert opinion on drug delivery·2026
Same journal

Next-generation strategies for PROTAC formulation: mechanistic insights and advanced formulation technologies.

Expert opinion on drug delivery·2026
Same journal

Drug penetration in solid tumors: influence of drug size and capillary architecture.

Expert opinion on drug delivery·2026
See all related articles

Polymeric nanoparticles show promise as safe and effective nonviral gene therapy vectors. Continued research aims to improve their efficiency for delivering therapeutic genes to diseased cells.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Nanomedicine

Background:

  • Gene therapy aims to treat diseases by delivering therapeutic genes.
  • Viral vectors are efficient but pose safety concerns.
  • Nonviral vectors offer a safer alternative but struggle with low transfection efficiency.

Purpose of the Study:

  • To review the potential of polymeric nanoparticles as gene expression vectors.
  • To highlight the importance of understanding disease pathophysiology in vector development.

Main Methods:

  • Review of current literature on gene therapy vectors.
  • Analysis of polymeric nanoparticles' properties for gene delivery.
  • Discussion of challenges and advancements in nonviral vector technology.

Related Experiment Videos

Main Results:

  • Polymeric nanoparticles present a viable nonviral gene delivery strategy.
  • Enhancing transfection efficiency is key to their clinical application.
  • Understanding disease mechanisms is crucial for targeted vector design.

Conclusions:

  • Polymeric nanoparticles are a promising avenue for safer gene therapy.
  • Further research is needed to optimize nonviral vector efficiency.
  • Integration of disease pathophysiology knowledge will advance vector development.